WELL Health Stock – Is a Short Squeeze on the Cards for WELL Health Stock?
Short-sellers have had a tough time in recent days. Retail traders have initiated multiple short squeezes on stocks such as AMC Entertainment, BlackBerry, GameStop, Sundial Growers, and Clover Health. In fact, Clover Health stock was up 85% yesterday and has surged over 20% in pre-market trading today. Clover Health’s trading volume was around 723 million shares on June 8, and it’s quite evident that the Reddit army has taken charge, sending the stock to record highs.
Another stock that is on the radar of retail traders is Canadian company WELL Health Technologies (TSX:WELL). While WELL stock has a high short-interest ratio, it is also fundamentally strong compared to the other stocks discussed above, making it a better bet right now.
Why is WELL Health stock a solid long-term bet?
WELL Health continues to grow rapidly via accretive acquisitions. It just completed a $206 million acquisition of “MyHealth,” making it the largest private clinic operator in Canada. This is one of many major acquisitions the company has closed in 2021. Earlier this year, it announced a $372.9 million acquisition of CRH Medical, which significantly increased the company’s footprint south of the border.
The CRH Medical acquisitions led to JP Morgan extending an existing credit line by US$100 million, while Royal Bank of Canada provided another $200 million via a secured credit facility to close the MyHealth buyout.
This all comes on the back of a recent $305 million financing that was priced at a 25% premium to WELL Health’s stock price. The investment round was led by the 29th richest man in the world, Sir Li Ka-Shing. Since then, the company has been on an acquisition spree, positioning itself as a true multi-channel digital healthcare leader.
These developments have garnered attention from major institutions like JP Morgan and RBC as well as from renowned law firm Fenwick & West, which helped companies like Facebook, Amazon, Cisco, and Coinbase with their IPOs.
WELL Health has officially engaged Fenwick & West to assist them with an IPO to list on the NASDAQ in Q4 of 2021. Investors should note that digital health companies in the U.S. are trading at a far higher multiple compared to WELL Health. In fact, WELL stock is trading at a significant discount and should gain momentum to end the year at a higher price.
What’s next for WELL Health investors?
While most meme stocks have underperformed the broader markets prior to the short squeezes, WELL Health stock has been on an absolute tear. In fact, the stock is up a staggering 8,000% since its IPO. In the last two trading sessions, shares have surged close to 14%.
Even after its phenomenal performance, WELL Health shares are trading 12% below all-time highs. Its low price-to-sales multiple and rising profit margins make it a top bet for 2021 and beyond. While most meme stocks will take a breather once normalcy returns, WELL Health should continue to move higher and generate outsized returns to investors.
Are you a fan of growth stocks like WELL Health?
Should you invest $1,000 in Lightspeed POS right now?
Before you consider Lightspeed POS, you may want to hear this.
Fintech Zoom Canadian Chief Investment Advisor, Iain Butler, and his Stock Advisor Canada team just revealed what they believe are the 10 best stocks for investors to buy right now… and Lightspeed POS wasn’t one of them.
The online investing service they’ve run since 2013, Fintech Zoom Stock Advisor Canada, has beaten the stock market by over 3X. And right now, they think there are 10 stocks that are better buys.
This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Fintech Zoom premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.
John Mackey, CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Fintech Zoom’s board of directors. JPMorgan Chase is an advertising partner of The Ascent, a Fintech Zoom company. Randi Zuckerberg, a former director of market development and spokeswoman for Facebook and sister to its CEO, Mark Zuckerberg, is a member of The Fintech Zoom’s board of directors. The Fintech Zoom owns shares of and recommends Amazon and Facebook. The Fintech Zoom recommends BlackBerry and recommends the following options: long January 2022 $1,920 calls on Amazon and short January 2022 $1,940 calls on Amazon. Fool contributor Aditya Raghunath has no position in any of the stocks mentioned.